Want to track AURA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aura Biosciences Inc. (AURA) Statistics
Valuation metrics
Market Cap 449.4M
Enterprise value 380.95M
Trailing P/E (ttm) -3.95
Forward P/E -
PEG ratio -0.59
Price/Sales (ttm) -
Price/Book (mrq) 4.4
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 802.54K
Average volume (90 days) 711.27K
Price summary
52-Week low 4.73
52-Week high 9.54
Beta -
50-Day moving average 6.81
200-Day moving average 6.41
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.82%
Return on equity -0.78%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.67
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.7
Total debt (mrq) -
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 7.09%
Book value per share (mrq) 1.59
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
